Telomir Pharmaceuticals, Inc. Common Stock (TELO)
TELO Stock Price Chart
Explore Telomir Pharmaceuticals, Inc. Common Stock interactive price chart. Choose custom timeframes to analyze TELO price movements and trends.
TELO Company Profile
Discover essential business fundamentals and corporate details for Telomir Pharmaceuticals, Inc. Common Stock (TELO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
9 Apr 2019
Employees
1.00
Website
https://telomirpharma.comCEO
Erez Aminov
Description
Telomir Pharmaceuticals, Inc. operates as a preclinical-stage pharmaceutical firm, concentrating its efforts on creating and launching novel therapeutic interventions. Its primary focus involves the development of TELOMIR-1, an innovative small molecule compound. This oral medication is being engineered to serve as a therapeutic solution against various age-related inflammatory conditions, such as hemochromatosis and osteoarthritis, and also to assist in recovery post-chemotherapy. It achieves this by disrupting and inhibiting inflammatory pathways that are triggered by interleukin-17. Established in 2021, the company was initially known as Metallo Therapies Inc., officially adopting the name Telomir Pharmaceuticals, Inc. on October 10, 2022. The company's headquarters are located in Baltimore, Maryland.
TELO Financial Timeline
Browse a chronological timeline of Telomir Pharmaceuticals, Inc. Common Stock corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 2 Sept 2026
EPS estimate is -$0.07.
Earnings released on 14 May 2026
EPS came in at -$0.03 surpassing the estimated -$0.07 by +57.14%.
Earnings released on 17 Mar 2026
EPS came in at -$0.06 surpassing the estimated -$0.07 by +14.29%.
Earnings released on 10 Nov 2025
EPS came in at -$0.03 surpassing the estimated -$0.07 by +57.14%.
Earnings released on 14 Aug 2025
EPS came in at -$0.17 falling short of the estimated -$0.08 by -112.50%.
Earnings released on 14 May 2025
EPS came in at -$0.07 surpassing the estimated -$0.10 by +30.00%.
Earnings released on 4 Feb 2025
EPS came in at -$0.10 falling short of the estimated -$0.05 by -100.00%, while revenue for the quarter reached $18.79m .
Earnings released on 12 Nov 2024
EPS came in at -$0.20 falling short of the estimated -$0.05 by -300.00%.
Earnings released on 13 Aug 2024
EPS came in at -$0.05 .
Earnings released on 13 May 2024
EPS came in at -$0.23 .
Earnings released on 29 Mar 2024
EPS came in at -$0.32 .
Earnings released on 30 Sept 2023
EPS came in at -$0.06 .
Earnings released on 30 Jun 2023
EPS came in at -$0.05 .
Earnings released on 31 Mar 2023
EPS came in at -$0.02 .
Earnings released on 31 Dec 2022
EPS came in at -$0.02 .
Earnings released on 29 Sept 2022
EPS came in at -$0.01 .
Earnings released on 29 Jun 2022
EPS came in at -$0.00 .
Earnings released on 31 Mar 2022
EPS came in at -$0.00 .
TELO Stock Performance
Access detailed TELO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
